+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Neuroendocrine Carcinoma"

Endothelial PAS domain-containing protein 1 inhibitors - Pipeline Insight, 2024 - Product Thumbnail Image

Endothelial PAS domain-containing protein 1 inhibitors - Pipeline Insight, 2024

  • Drug Pipelines
  • January 2024
  • 60 Pages
  • Global
From
Neuroendocrine Tumors - Epidemiology Forecast to 2032 - Product Thumbnail Image

Neuroendocrine Tumors - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Gastric Neuroendocrine Tumors - Epidemiology Forecast to 2032 - Product Thumbnail Image

Gastric Neuroendocrine Tumors - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs) - Epidemiology Forecast to 2032 - Product Thumbnail Image

Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs) - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs) - Market Insight, Epidemiology and Market Forecast -2032 - Product Thumbnail Image

Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs) - Market Insight, Epidemiology and Market Forecast -2032

  • Report
  • January 2022
  • 224 Pages
  • Global
From
Neuroendocrine Carcinoma - Epidemiology Forecast to 2032 - Product Thumbnail Image

Neuroendocrine Carcinoma - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Neuroendocrine Carcinoma Market Report and Forecast 2024-2032 - Product Thumbnail Image

Neuroendocrine Carcinoma Market Report and Forecast 2024-2032

  • Report
  • February 2024
  • 180 Pages
  • Global
From
Neuroendocrine Tumor Treatment Market - Global Industry Size, Share, Trends, Competition, Opportunity and Forecast, 2018-2028 Segmented By Product Analysis, By Site Analysis, By End User, By Region and Competition - Product Thumbnail Image

Neuroendocrine Tumor Treatment Market - Global Industry Size, Share, Trends, Competition, Opportunity and Forecast, 2018-2028 Segmented By Product Analysis, By Site Analysis, By End User, By Region and Competition

  • Report
  • March 2023
  • 117 Pages
  • Global
From
Neuroendocrine Tumor Treatment Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027) - Product Thumbnail Image

Neuroendocrine Tumor Treatment Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

  • Report
  • October 2022
  • 113 Pages
  • Global
From
Radioligand Therapy Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027 - Product Thumbnail Image

Radioligand Therapy Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027

  • Report
  • June 2023
  • 119 Pages
  • Global
From
Neuroendocrine Tumors Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape - Product Thumbnail Image

Neuroendocrine Tumors Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape

  • Report
  • May 2022
  • 76 Pages
  • Global
From
Neuroendocrine Tumors - Global Drug Forecast and Market Analysis to 2030 - Product Thumbnail Image

Neuroendocrine Tumors - Global Drug Forecast and Market Analysis to 2030

  • Report
  • September 2021
  • 126 Pages
  • Global
From
North America Gastric Cancer Market Size, Share & Industry Trends Analysis Report By Route of Administration (Injectable and Oral), By Treatment Type, By Disease Type, By Distribution Channel, By Drug Class, By Country and Growth Forecast, 2023-2029 - Product Thumbnail Image

North America Gastric Cancer Market Size, Share & Industry Trends Analysis Report By Route of Administration (Injectable and Oral), By Treatment Type, By Disease Type, By Distribution Channel, By Drug Class, By Country and Growth Forecast, 2023-2029

  • Report
  • April 2023
  • 112 Pages
  • North America
From
Global Neuroendocrine Tumor Clinical Trial Pipeline Highlights - 2022 - Product Thumbnail Image

Global Neuroendocrine Tumor Clinical Trial Pipeline Highlights - 2022

  • Report
  • August 2022
  • Global
From
Cellular Tumor Antigen p53 - Pipeline Review, H2 2019 - Product Thumbnail Image

Cellular Tumor Antigen p53 - Pipeline Review, H2 2019

  • Drug Pipelines
  • December 2019
  • 134 Pages
  • Global
From
Market Spotlight: Neuroendocrine tumors (NET) - Product Thumbnail Image

Market Spotlight: Neuroendocrine tumors (NET)

  • Report
  • May 2021
  • 42 Pages
  • Global
Cancer mTOR Inhibitor Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type - Product Thumbnail Image

Cancer mTOR Inhibitor Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • August 2024
  • 95 Pages
  • Global
From
Somatostatin Analog Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type - Product Thumbnail Image

Somatostatin Analog Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • October 2023
  • 77 Pages
  • Global
From
Neuroendocrine Carcinoma Drug Global Market Insights 2023, Analysis and Forecast to 2028, by Market Participants, Regions, Technology, Application, Product Type - Product Thumbnail Image

Neuroendocrine Carcinoma Drug Global Market Insights 2023, Analysis and Forecast to 2028, by Market Participants, Regions, Technology, Application, Product Type

  • Report
  • June 2023
  • 110 Pages
  • Global
From
Bcl 2 Like Protein 1 (Apoptosis Regulator BclX or BCLX or BCL2L1) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Bcl 2 Like Protein 1 (Apoptosis Regulator BclX or BCLX or BCL2L1) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • November 2022
  • 71 Pages
  • Global
From
Loading Indicator

Neuroendocrine carcinoma (NEC) is a rare type of cancer that affects the neuroendocrine system, which is responsible for the production of hormones. It is a type of cancer that is often difficult to diagnose and treat. Treatment options for NEC include surgery, chemotherapy, radiation therapy, and targeted therapies. Oncology drugs are used to treat NEC, and they can be used alone or in combination with other treatments. These drugs can help to reduce the size of tumors, slow the growth of cancer cells, and reduce the risk of recurrence. The Neuroendocrine Carcinoma market is a rapidly growing segment of the oncology drugs market. It is driven by the increasing prevalence of NEC, the development of new treatments, and the increasing availability of targeted therapies. Companies in the market include Novartis, Pfizer, Merck, AstraZeneca, and Roche. Show Less Read more